Cerapedics, Inc., a pioneering biotechnology firm headquartered in the United States, specialises in innovative orthobiologics for bone repair and regeneration. Founded in 2007, the company has made significant strides in the field, particularly with its proprietary i-FACTOR® Peptide Enhanced Bone Graft, which uniquely combines a synthetic peptide with a mineral-based scaffold to enhance bone healing. With a strong presence in the orthopaedic and spinal surgery markets, Cerapedics has established itself as a leader in the development of advanced bone graft solutions. The company’s commitment to research and development has led to numerous clinical studies, reinforcing its position as a trusted provider in the industry. Cerapedics continues to push the boundaries of regenerative medicine, aiming to improve patient outcomes through its cutting-edge products.
How does Cerapedics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cerapedics, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cerapedics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Cerapedics may not yet have established a comprehensive framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, Cerapedics may need to consider developing measurable targets and strategies to align with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cerapedics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
